David W. Tonge

IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells

Claire M. Perks, Ellen G Vernon, AH Rosendahl et al. · Oncogene · 2007 · 167 citations

Medicine, Molecular Biology, Oncology +11

Purification and Characterization of Active and Stable Recombinant Plasminogen‐Activator Inhibitor Accumulated at High Levels in <i>Escherichia coli</i>

Elena Sancho, David W. Tonge, Robert C. Hockney et al. · European Journal of Biochemistry · 1994 · 67 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells

Helen Jones, Julia M.W. Gee, Denise Barrow et al. · British Journal of Cancer · 2006 · 48 citations · Full text

Medicine, Oncology, Pharmacology +15

Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice

Yoram Reiter, Andrew F. Wright, David W. Tonge et al. · International Journal of Cancer · 1996 · 26 citations

Pharmacy, Molecular Biology, Oncology +17

Rapid Induction of IGF-IR Signaling in Normal and Tumor Tissue Following Intravenous Injection of IGF-I in Mice

A. V. Lee, Samuel Taylor, J. Greenall et al. · Hormone and Metabolic Research · 2003 · 23 citations

Life Sciences, Cancer Biology, Oncology +10